Filing Flows › IGC Pharma (IGC) › White Labeling Services revenue
IGC Pharma (IGC) White Labeling Services revenue by quarter
IGC Pharma's White Labeling Services revenue was $321K in Q3 2026 (third quarter 2026), +25% from Q2 2026. Over the last 6 quarters it ranged from $153K (Q3 2025) to $322K (Q2 2025).
| Quarter | White Labeling Services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $321K | +25% | +110% |
| Q2 2026 | $256K | -13% | -20% |
| Q1 2026 | $294K | +92% | — |
| Q3 2025 | $153K | -52% | — |
| Q2 2025 | $322K | +44% | — |
| Q4 2024 | $223K | — | — |
Q3 2026 at a glance
IGC Pharma, Q3 2026: revenue $328K (+72% year over year), operating margin -588.7%, net loss $2.0M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is IGC Pharma's White Labeling Services revenue?
IGC Pharma's White Labeling Services revenue was $321K in Q3 2026 (third quarter 2026), +25% from Q2 2026.
How has IGC Pharma's White Labeling Services revenue changed?
Over the last 6 quarters it ranged from $153K (Q3 2025) to $322K (Q2 2025).